{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:49:57Z","timestamp":1790675397488,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:00:00Z","timestamp":1532649600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","award":["Pilot Award"],"award-info":[{"award-number":["Pilot Award"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1661-5","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T09:29:28Z","timestamp":1532683768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance"],"prefix":"10.1186","volume":"20","author":[{"given":"Raini","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Lunzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Auger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyup","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Portoghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3127-3856","authenticated-orcid":false,"given":"Bryce A.","family":"Binstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,27]]},"reference":[{"issue":"Suppl 107","key":"1661_CR1","first-page":"94","volume":"35","author":"DF McWilliams","year":"2017","unstructured":"McWilliams DF, Walsh DA. Pain mechanisms in rheumatoid arthritis. Clin Exp Rheumatol. 2017;35(Suppl 107):94\u2013101.","journal-title":"Clin Exp Rheumatol"},{"key":"1661_CR2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra1507771","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, McLellan AT. Opioid abuse in chronic pain\u2014misconceptions and mitigation strategies. N Engl J Med. 2016;374:1253\u201363.","journal-title":"N Engl J Med"},{"key":"1661_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tips.2013.03.006","volume":"34","author":"C Stein","year":"2013","unstructured":"Stein C, Kuchler S. Targeting inflammation and wound healing by opioids. Trends Pharmacol Sci. 2013;34:303\u201312.","journal-title":"Trends Pharmacol Sci"},{"key":"1661_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrn3858","volume":"16","author":"S Melik Parsadaniantz","year":"2015","unstructured":"Melik Parsadaniantz S, Rivat C, Rostene W, Reaux-Le Goazigo A. Opioid and chemokine receptor crosstalk: a promising target for pain therapy? Nat Rev Neurosci. 2015;16:69\u201378.","journal-title":"Nat Rev Neurosci"},{"key":"1661_CR5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/art.20932","volume":"52","author":"AE Koch","year":"2005","unstructured":"Koch AE. Chemokines and their receptors in rheumatoid arthritis: future targets? Arthritis Rheum. 2005;52:710\u201321.","journal-title":"Arthritis Rheum"},{"key":"1661_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/gene.2010.25","volume":"11","author":"A Hinks","year":"2010","unstructured":"Hinks A, Martin P, Flynn E, Eyre S, Packham J, Barton A, Worthington J, Thomson W. Association of the CCR5 gene with juvenile idiopathic arthritis. Genes Immun. 2010;11:584\u20139.","journal-title":"Genes Immun"},{"key":"1661_CR7","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1186\/ar3685","volume":"14","author":"DL Fleishaker","year":"2012","unstructured":"Fleishaker DL, Garcia Meijide JA, Petrov A, Kohen MD, Wang X, Menon S, Stock TC, Mebus CA, Goodrich JM, Mayer HB, Zeiher BG. Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial. Arthritis Res Ther. 2012;14:R11.","journal-title":"Arthritis Res Ther."},{"key":"1661_CR8","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1002\/art.27652","volume":"62","author":"DM Gerlag","year":"2010","unstructured":"Gerlag DM, Hollis S, Layton M, Vencovsky J, Szekanecz Z, Braddock M, Tak PP. Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate. Arthritis Rheum. 2010;62:3154\u201360.","journal-title":"Arthritis Rheum"},{"key":"1661_CR9","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1136\/ard.2010.131235","volume":"69","author":"AW van Kuijk","year":"2010","unstructured":"van Kuijk AW, Vergunst CE, Gerlag DM, Bresnihan B, Gomez-Reino JJ, Rouzier R, Verschueren PC, van der Leij C, Maas M, Kraan MC, Tak PP. CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial. Ann Rheum Dis. 2010;69:2013\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1661_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejphar.2003.10.033","volume":"483","author":"C Chen","year":"2004","unstructured":"Chen C, Li J, Bot G, Szabo I, Rogers TJ, Liu-Chen LY. Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur J Pharmacol. 2004;483:175\u201386.","journal-title":"Eur J Pharmacol"},{"key":"1661_CR11","doi-asserted-by":"publisher","first-page":"8647","DOI":"10.1021\/acs.jmedchem.5b01245","volume":"58","author":"E Akgun","year":"2015","unstructured":"Akgun E, Javed MI, Lunzer MM, Powers MD, Sham YY, Watanabe Y, Portoghese PS. Inhibition of inflammatory and neuropathic pain by targeting a mu opioid receptor\/chemokine receptor 5 heteromer (MOR-CCR5). J Med Chem. 2015;58:8647\u201357.","journal-title":"J Med Chem"},{"key":"1661_CR12","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1128\/AAC.49.8.3474-3482.2005","volume":"49","author":"K Takashima","year":"2005","unstructured":"Takashima K, Miyake H, Kanzaki N, Tagawa Y, Wang X, Sugihara Y, Iizawa Y, Baba M. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist. Antimicrob Agents Chemother. 2005;49:3474\u201382.","journal-title":"Antimicrob Agents Chemother"},{"key":"1661_CR13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0022-3565(25)13379-X","volume":"247","author":"RB Rothman","year":"1988","unstructured":"Rothman RB, Long JB, Bykov V, Jacobson AE, Rice KC, Holaday JW. Beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence. J Pharmacol Exp Ther. 1988;247:405\u201316.","journal-title":"J Pharmacol Exp Ther"},{"key":"1661_CR14","doi-asserted-by":"publisher","first-page":"11595","DOI":"10.1073\/pnas.1305461110","volume":"110","author":"E Akgun","year":"2013","unstructured":"Akgun E, Javed MI, Lunzer MM, Smeester BA, Beitz AJ, Portoghese PS. Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception. Proc Natl Acad Sci U S A. 2013;110:11595\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Unit 15","key":"1661_CR15","first-page":"22","volume":"Chapter 15","author":"PA Monach","year":"2008","unstructured":"Monach PA, Mathis D, Benoist C. The K\/BxN arthritis model. Curr Protoc Immunol. 2008;Chapter 15(Unit 15):22.","journal-title":"Curr Protoc Immunol"},{"key":"1661_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0021-9150(02)00382-9","volume":"167","author":"WA Kuziel","year":"2003","unstructured":"Kuziel WA, Dawson TC, Quinones M, Garavito E, Chenaux G, Ahuja SS, Reddick RL, Maeda N. CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis. 2003;167:25\u201332.","journal-title":"Atherosclerosis"},{"key":"1661_CR17","doi-asserted-by":"publisher","first-page":"R269","DOI":"10.1186\/ar4117","volume":"14","author":"JL Auger","year":"2012","unstructured":"Auger JL, Haasken SS, Binstadt BA. Autoantibody-mediated arthritis in the absence of C3 and activating Fcgamma receptors: C5 is activated by the coagulation cascade. Arthritis Res Ther. 2012;14:R269.","journal-title":"Arthritis Res Ther"},{"key":"1661_CR18","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.4049\/jimmunol.1000967","volume":"187","author":"S Haasken","year":"2011","unstructured":"Haasken S, Auger JL, Binstadt BA. Absence of beta2 integrins impairs regulatory T cells and exacerbates CD4+ T cell-dependent autoimmune carditis. J Immunol. 2011;187:2702\u201310.","journal-title":"J Immunol"},{"key":"1661_CR19","first-page":"51012","volume":"82","author":"BN Gaskill","year":"2013","unstructured":"Gaskill BN, Karas AZ, Garner JP, Pritchett-Corning KR. Nest building as an indicator of health and welfare in laboratory mice. J Vis Exp. 2013;82:51012.","journal-title":"J Vis Exp"},{"key":"1661_CR20","first-page":"65","volume-title":"Molecular histopathology and tissue biomarkers in drug and diagnostic development","author":"P Caplazi","year":"2015","unstructured":"Caplazi P, Diehl L. Histopathology in mouse models of rheumatoid arthritis. In: Potts SJ, Eberhard DA, Wharton KA, editors. Molecular histopathology and tissue biomarkers in drug and diagnostic development. New York: Springer; 2015. p. 65\u201378."},{"key":"1661_CR21","first-page":"1341","volume":"151","author":"JB Rottman","year":"1997","unstructured":"Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol. 1997;151:1341\u201351.","journal-title":"Am J Pathol"},{"key":"1661_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.brainresrev.2008.12.002","volume":"60","author":"C Abbadie","year":"2009","unstructured":"Abbadie C, Bhangoo S, De Koninck Y, Malcangio M, Melik-Parsadaniantz S, White FA. Chemokines and pain mechanisms. Brain Res Rev. 2009;60:125\u201334.","journal-title":"Brain Res Rev"},{"key":"1661_CR23","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/art.27470","volume":"62","author":"JP Jacobs","year":"2010","unstructured":"Jacobs JP, Ortiz-Lopez A, Campbell JJ, Gerard CJ, Mathis D, Benoist C. Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis Rheum. 2010;62:1921\u201332.","journal-title":"Arthritis Rheum"},{"key":"1661_CR24","first-page":"327257","volume":"2012","author":"MD Aceto","year":"2012","unstructured":"Aceto MD, Harris LS, Negus SS, Banks ML, Hughes LD, Akgun E, Portoghese PS. MDAN-21: a bivalent opioid ligand containing mu-agonist and delta-antagonist pharmacophores and its effects in rhesus monkeys. Int J Med Chem. 2012;2012:327257.","journal-title":"Int J Med Chem"},{"key":"1661_CR25","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/jm4005219","volume":"56","author":"M Le Naour","year":"2013","unstructured":"Le Naour M, Akgun E, Yekkirala A, Lunzer MM, Powers MD, Kalyuzhny AE, Portoghese PS. Bivalent ligands that target mu opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance. J Med Chem. 2013;56:5505\u201313.","journal-title":"J Med Chem"},{"key":"1661_CR26","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1126\/science.aai8636","volume":"355","author":"V Spahn","year":"2017","unstructured":"Spahn V, Del Vecchio G, Labuz D, Rodriguez-Gaztelumendi A, Massaly N, Temp J, Durmaz V, Sabri P, Reidelbach M, Machelska H, Weber M, Stein C. A nontoxic pain killer designed by modeling of pathological receptor conformations. Science. 2017;355:966\u20139.","journal-title":"Science"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1661-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1661-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1661-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T02:15:51Z","timestamp":1751768151000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1661-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,27]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1661-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,27]]},"assertion":[{"value":"22 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studies were approved by the University of Minnesota Institutional Animal Care and Use Committee, protocol 1506-32700A.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"154"}}